Title:
SPIRO RING COMPOUNDS AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
Japanese Patent JP2017132787
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide a medicament for modulating the function of GPR40, in particular, a medicament as GPR40 agonist for treating or preventing diabetes mellitus, hyperglycemia, impaired glucose tolerance, impaired fasting glucose and the like.SOLUTION: The invention provides a spiro ring compound represented by the general formula [Ia] in the figure, its pharmaceutically acceptable salt or a solvate thereof.SELECTED DRAWING: None
Inventors:
SHIMADA TAKASHI
UENO HIROSHI
TSUTSUMI KAZUHIRO
AOYANAGI KOICHI
MANABE TOMOYUKI
SASAKI SHINYA
KATO SUSUMU
UENO HIROSHI
TSUTSUMI KAZUHIRO
AOYANAGI KOICHI
MANABE TOMOYUKI
SASAKI SHINYA
KATO SUSUMU
Application Number:
JP2017049246A
Publication Date:
August 03, 2017
Filing Date:
March 14, 2017
Export Citation:
Assignee:
JAPAN TOBACCO INC
International Classes:
C07C29/147; A61K31/192; A61K31/41; A61K31/421; A61K31/426; A61K31/44; A61P3/10; A61P43/00; C07C33/12; C07C33/14; C07C33/16; C07C59/54; C07C59/66; C07C59/82; C07C235/34; C07D213/64; C07D257/04; C07D263/32; C07D277/34; C07F7/18
Domestic Patent References:
| JP2004169002A | 2004-06-17 | |||
| JP2005015461A | 2005-01-20 |
Foreign References:
| WO2005051373A1 | 2005-06-09 | |||
| WO2006011615A1 | 2006-02-02 |
Attorney, Agent or Firm:
Ryu Iwatani
Previous Patent: The vaccine containing NEIL3 peptide and it
Next Patent: A preparing method of a trialkyl gallium compound
Next Patent: A preparing method of a trialkyl gallium compound